North America DNA Vaccine Market to Reach $711.7 Million by 2035

North America DNA vaccine market was valued at $450.4 million in 2025 and is projected to reach $711.7 million by 2035, registering a CAGR of 4.8% over the forecast period from 2026 to 2035. The North America DNA Vaccine market is accelerating as biotech innovation prioritizes rapid development platforms that address emerging infectious threats and complex diseases. Recent initiatives are advancing the use of DNA vaccine technologies that enable faster design and scalable manufacturing. The robust ecosystem of research institutions, federal funding, and private partnerships is contributing to deeper engagement with plasmid DNA vaccine candidates across both infectious disease and therapeutic applications. This structural momentum directly supports growth across the plasmid DNA vaccines and delivery technology segments, reinforcing North America’s standing as a global leader in DNA vaccine innovation.

Browse the full report description of “North America DNA Vaccine Market Size, Share & Trends Analysis Report by Type (Animal DNA Vaccine, and Human DNA Vaccine), by Technology (Plasmid DNA Vaccines Technology, and Plasmid DNA Delivery Technology), by Application (Oncology, Infectious Diseases, and Others), Forecast Period 2026-2035” at https://www.omrglobal.com/industry-reports/north-american-dna-vaccines-market

In 2024, Applied DNA Sciences, Inc. and partner HDT Bio announced a Rapid Vaccine Development Program focused on accelerating plasmid DNA?based vaccine candidates, highlighting regional commitment to streamlined response capabilities. According to the National Institutes of Health and federal funding data, the U.S. continues to allocate significant research investment to gene?based vaccine platforms, underpinning clinical pipeline expansion. Public clinical trial registries show hundreds of ongoing DNA vaccine studies across North America, reinforcing sustained scientific activity. These developments reflect how strategic prioritization and technical capacity are shaping the regional market trajectory.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • Type
  • Technology
  • Application
• Competitive Landscape – Applied DNA Sciences, Inc., INOVIO Pharmaceuticals, Inc., Pfizer Inc., Thermo Fisher Scientific Inc., Zoetis Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

North America DNA Vaccine Market Report Segment

By Type

• Animal DNA Vaccine
• Human DNA Vaccine

By Technology

• Plasmid DNA Vaccines Technology
• Plasmid DNA Delivery Technology

By Application

• Oncology
• Infectious Diseases
• Others

North America DNA Vaccine Market Report Segment by Country

• United States
• Canada

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/north-american-dna-vaccines-market